Logo image of ALEXP.PA

ONE EXPERIENCE (ALEXP.PA) Stock Fundamental Analysis

EPA:ALEXP - Euronext Paris - Matif - FR0013266772 - Common Stock - Currency: EUR

0.3  +0.01 (+2.74%)

Fundamental Rating

2

Overall ALEXP gets a fundamental rating of 2 out of 10. We evaluated ALEXP against 50 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of ALEXP have multiple concerns. ALEXP does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

ALEXP had negative earnings in the past year.
In the past year ALEXP had a positive cash flow from operations.
ALEXP.PA Yearly Net Income VS EBIT VS OCF VS FCFALEXP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 200K -200K 400K -400K -600K -800K

1.2 Ratios

With a Return On Assets value of -8.82%, ALEXP is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
ALEXP has a Return On Equity of -15.81%. This is in the lower half of the industry: ALEXP underperforms 62.00% of its industry peers.
Industry RankSector Rank
ROA -8.82%
ROE -15.81%
ROIC N/A
ROA(3y)-3.71%
ROA(5y)N/A
ROE(3y)-7.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALEXP.PA Yearly ROA, ROE, ROICALEXP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -2 -4 -6 -8

1.3 Margins

Looking at the Gross Margin, with a value of 39.77%, ALEXP is doing worse than 62.00% of the companies in the same industry.
ALEXP's Gross Margin has declined in the last couple of years.
ALEXP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.49%
GM growth 5YN/A
ALEXP.PA Yearly Profit, Operating, Gross MarginsALEXP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 40 -40 60 80

3

2. Health

2.1 Basic Checks

ALEXP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALEXP has more shares outstanding
ALEXP has a better debt/assets ratio than last year.
ALEXP.PA Yearly Shares OutstandingALEXP.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M
ALEXP.PA Yearly Total Debt VS Total AssetsALEXP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of 0.18, we must say that ALEXP is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.18, ALEXP is doing worse than 78.00% of the companies in the same industry.
The Debt to FCF ratio of ALEXP is 5.47, which is a neutral value as it means it would take ALEXP, 5.47 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.47, ALEXP is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
ALEXP has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALEXP (0.27) is better than 74.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.47
Altman-Z 0.18
ROIC/WACCN/A
WACC5.76%
ALEXP.PA Yearly LT Debt VS Equity VS FCFALEXP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M 4M 6M 8M

2.3 Liquidity

ALEXP has a Current Ratio of 0.95. This is a bad value and indicates that ALEXP is not financially healthy enough and could expect problems in meeting its short term obligations.
ALEXP has a Current ratio (0.95) which is in line with its industry peers.
A Quick Ratio of 0.95 indicates that ALEXP may have some problems paying its short term obligations.
ALEXP has a Quick ratio of 0.95. This is comparable to the rest of the industry: ALEXP outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
ALEXP.PA Yearly Current Assets VS Current LiabilitesALEXP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M 4M

3

3. Growth

3.1 Past

The earnings per share for ALEXP have decreased strongly by -76.86% in the last year.
The Revenue has grown by 84.09% in the past year. This is a very strong growth!
ALEXP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 91.23% yearly.
EPS 1Y (TTM)-76.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103%
Revenue 1Y (TTM)84.09%
Revenue growth 3Y91.23%
Revenue growth 5YN/A
Sales Q2Q%67.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEXP.PA Yearly Revenue VS EstimatesALEXP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 1M 2M 3M 4M 5M

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALEXP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALEXP.PA Price Earnings VS Forward Price EarningsALEXP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

ALEXP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ALEXP is cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.9
EV/EBITDA N/A
ALEXP.PA Per share dataALEXP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALEXP!.
Industry RankSector Rank
Dividend Yield N/A

ONE EXPERIENCE

EPA:ALEXP (4/25/2025, 7:00:00 PM)

0.3

+0.01 (+2.74%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners13.57%
Inst Owner ChangeN/A
Ins Owners37.9%
Ins Owner ChangeN/A
Market Cap2.75M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF 7.9
P/OCF 5.23
P/B 0.38
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY12.66%
OCF(TTM)0.06
OCFY19.1%
SpS0.66
BVpS0.78
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.82%
ROE -15.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.77%
FCFM 5.73%
ROA(3y)-3.71%
ROA(5y)N/A
ROE(3y)-7.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.49%
GM growth 5YN/A
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.47
Debt/EBITDA N/A
Cap/Depr 63.21%
Cap/Sales 2.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z 0.18
F-Score5
WACC5.76%
ROIC/WACCN/A
Cap/Depr(3y)180.68%
Cap/Depr(5y)N/A
Cap/Sales(3y)18.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)84.09%
Revenue growth 3Y91.23%
Revenue growth 5YN/A
Sales Q2Q%67.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3727.27%
OCF growth 3YN/A
OCF growth 5YN/A